E-DRUG: A suggestion for improving Access to genuine drugs
--------------------------------------------------------
Dear E-Druggers,
May I suggest a solution that would considerably reduce counterfeiting
if successfully implemented? Developed Countries Governments, NGOs and
International Organizations (WTO, WIPO, WHO and its IMPACT programme, etc.
and the Pharmaceutical Industry worldwide) should should set up a FUND which
would make it possible for genuine drugs to be available in ALL LDCs at a
cost which their economy can bear. If a brand name medication costs 1 USD in
the USA, 1 UK Pound in the UK, 1 Franc in France, Belgium or Switzerland
etc. it should cost only 1 unit of each LDC Currency. This way, the
counterfeiters and smugglers will be put out of business while more needy
patients in the LDCs will be able to have access to the drugs they need and
there will be no NEED for EU to seize any drug shipment!!!
The Fund should also be used to upgrade the level of Information,
Education and Communication (IEC) in LDCs so that their entire population
can reap the benefit of such IEC.
A F Biola Mabadeje
Retired Professor of Clinical Pharmacology of University of Lagos Nigeria
Retired INRUD Nigeria Group President and Coordinator
Biola Mabadeje <biolamab@gmail.com>
E-DRUG: A suggestion for improving Access to genuine drugs (2)
----------------------------------------------------
Dear all,
the suggestion of retired Prof. Mabadeje may or may not work in public health supply but certainly not in the private market sector including those of developing countries eg India and Nigeria where each and every trader want to take its cut. There are proven cases of antimalarial medicines dispensed entirely for free in the public market arena in SEA and still counterfeiting was going on in the private market because consumer were not aware that drugs are available for free elsewhere.
Best regards
Richard Jaehnke (PhD)
Global Pharma Health Fund (GPHF)
Frankfurt, Germany, www.gphf.org
gphf@aol.com
E-DRUG: A suggestion for improving Access to genuine drugs (3)
---------------------------------------------------
Dear Professor Mabadeje,
You may find a recent article published in Malaria Journal on a new financing platform, the Affordable Medicines Facility -malaria, not too distant from your suggestion below. A link to the article is below.
http://www.malariajournal.com/content/pdf/1475-2875-9-274.pdf
Dr Lloyd Matowe
Lloyd Matowe <samanyika@hotmail.com>
[Please, always include affiliation and country]
E-DRUG: A suggestion for improving Access to genuine drugs (3)
---------------------------------------------------
Dear eDruggers;
I like very much Biola Mabadeje's suggestion. But, let me propose that this measure would be only a stop-gap for a preferred solution.
A rotating stockpile of medicines provided from the outside is still fundamentally dependent upon subsidies. Does anyone reading this message feel that dependency upon subsidized drug production from outside Africa is the ultimate solution?? And, the "rotating stockpile" - if the medicines come from outside Africa, what impact will it have on the development of quality-assured medicines production in Africa?
I suggest a preferred approach can be developed through the "soon-to-come" promised, joint effort from the World Bank and the Gates Foundation - Harmonized Registration Requirements for pharmaceuticals. The surest way to eliminate counterfeit and substandard drugs is to train National Drug Regulatory Authorities to meet Strict Regulatory Authority requirements.
Joseph M. Fortunak
Associate Professor
Chemistry and Pharmaceutical Sciences
Howard University
525 College Street NW
Washington, DC 20059 USA
+1 202 806 6880 (office)
+1 301 928 7568 (mobile)
jfortunak@comcast.net